- Home
- ACOG vs PHUN Comparison
ACOG vs PHUN Comparison
Compare ACOG & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACOG | PHUN |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 55.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ACOG | PHUN |
|---|---|---|
| Price | $5.45 | $1.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $7.25 |
| AVG Volume (30 Days) | 79.3K | ★ 150.4K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,427,199.00 | $2,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $143.70 | $73.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.75 | $1.83 |
| 52 Week High | $11.54 | $6.29 |
Technical Indicators
Market Signals| Indicator | ACOG | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 30.22 |
| Support Level | $4.99 | $2.01 |
| Resistance Level | $6.74 | $2.12 |
| Average True Range (ATR) | 0.48 | 0.10 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 21.71 | 0.00 |
Price Performance
Historical ComparisonAbout ACOG Alpha Cognition Inc.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.